Amgen's $13.4bn Otezla Buy Helps Bristol/Celgene Merger Close By Year-End

 
• By Mandy Jackson
  
GoldKeyInPuzzle_1200x675
Selling Otezla to appease the FTC is key to closing the Bristol-Celgene merger on time. • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business